Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-13
2010-06-29
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S311000, C514S332000, C514S438000, C514S464000, C514S443000, C514S461000, C514S468000, C514S469000, C514S557000, C544S335000, C546S174000, C546S342000, C549S029000, C549S031000, C549S032000, C549S429000, C549S433000, C549S434000, C560S055000
Reexamination Certificate
active
07745445
ABSTRACT:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPARδ.
REFERENCES:
patent: 6555577 (2003-04-01), Morgensen
patent: 08333287 (1996-12-01), None
patent: WO 92/01675 (1992-02-01), None
patent: WO 02/076438 (2002-10-01), None
patent: WO03084916 (2003-10-01), None
Azimioara Mihai
Epple Robert
Davis Zinna N
Genomics Institute of the Novartis Research Foundation
IRM LLC
Reid Scott W.
LandOfFree
Compounds and compositions as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as PPAR modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4192042